Start Codon is a world-class life science and healthcare venture capital fund and venture studio that offers significant funding and business support to rapidly translate the most disruptive and innovative research into successful start-up companies.

Each of its portfolio companies receives a minimum of £250k seed funding (with follow-on funding also a possibility) to enable essential proof-of-concept experiments to be performed and/or product development to be accelerated and to equip the founders and their teams with the skills and resources they need to succeed and secure follow-on rounds of financing. Through Start Codon’s venture studio, Start Codon provides all founders of its portfolio companies with access to Start Codon’s ‘START’ programme, which is tailored to the individual needs of each portfolio company.

The START programme provides founders with access to Start Codon’s experienced management team, includes access to pharma and industry partners, mentorship from leading industry experts and serially successful entrepreneurs, introductions to Start Codon’s network of follow-on angel, venture capital and other strategic investors, assistance with the drafting and production of business plans and the setting up and spinning out of companies from institutions (where applicable).